These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 30992523)

  • 1. Cell therapy for Parkinson's disease is coming of age: current challenges and future prospects with a focus on immunomodulation.
    Wenker SD; Pitossi FJ
    Gene Ther; 2020 Feb; 27(1-2):6-14. PubMed ID: 30992523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell therapy for Parkinson's disease: Functional role of the host immune response on survival and differentiation of dopaminergic neuroblasts.
    Wenker SD; Leal MC; Farías MI; Zeng X; Pitossi FJ
    Brain Res; 2016 May; 1638(Pt A):15-29. PubMed ID: 26239914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advancing Parkinson's disease treatment: cell replacement therapy with neurons derived from pluripotent stem cells.
    Clark BJ; Lelos MJ; Loring JF
    Stem Cells; 2024 Sep; 42(9):781-790. PubMed ID: 38902932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell Therapy for Parkinson's Disease.
    Yasuhara T; Kameda M; Sasaki T; Tajiri N; Date I
    Cell Transplant; 2017 Sep; 26(9):1551-1559. PubMed ID: 29113472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining physical & cognitive training with iPSC-derived dopaminergic neuron transplantation promotes graft integration & better functional outcome in parkinsonian marmosets.
    Daadi EW; Daadi ES; Oh T; Li M; Kim J; Daadi MM
    Exp Neurol; 2024 Apr; 374():114694. PubMed ID: 38272159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of transcription factors in cell replacement therapies for neurodegenerative conditions.
    Thomas M
    Regen Med; 2010 May; 5(3):441-50. PubMed ID: 20455654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress in Dopaminergic Cell Replacement and Regenerative Strategies for Parkinson's Disease.
    Chen W; Huang Q; Ma S; Li M
    ACS Chem Neurosci; 2019 Feb; 10(2):839-851. PubMed ID: 30346716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem Cell Therapy for the Treatment of Parkinson's Disease: What Promise Does it Hold?
    Nasrolahi A; Shabani Z; Sadigh-Eteghad S; Salehi-Pourmehr H; Mahmoudi J
    Curr Stem Cell Res Ther; 2024; 19(2):185-199. PubMed ID: 36815638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Rho Kinase Inhibitors on Grafts of Dopaminergic Cell Precursors in a Rat Model of Parkinson's Disease.
    Rodriguez-Pallares J; Rodriguez-Perez AI; Muñoz A; Parga JA; Toledo-Aral JJ; Labandeira-Garcia JL
    Stem Cells Transl Med; 2016 Jun; 5(6):804-15. PubMed ID: 27075764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Past, present, and future of cell replacement therapy for parkinson's disease: a novel emphasis on host immune responses.
    Park TY; Jeon J; Cha Y; Kim KS
    Cell Res; 2024 Jul; 34(7):479-492. PubMed ID: 38777859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem cells and the treatment of Parkinson's disease.
    Ali F; Stott SR; Barker RA
    Exp Neurol; 2014 Oct; 260():3-11. PubMed ID: 23298521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The future of cell therapies and brain repair: Parkinson's disease leads the way.
    Petit GH; Olsson TT; Brundin P
    Neuropathol Appl Neurobiol; 2014 Feb; 40(1):60-70. PubMed ID: 24372386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replacing what's lost: a new era of stem cell therapy for Parkinson's disease.
    Fan Y; Winanto ; Ng SY
    Transl Neurodegener; 2020; 9():2. PubMed ID: 31911835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Embryonic and adult stem cells as a source for cell therapy in Parkinson's disease.
    Levy YS; Stroomza M; Melamed E; Offen D
    J Mol Neurosci; 2004; 24(3):353-86. PubMed ID: 15655260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem Cells for Modeling and Therapy of Parkinson's Disease.
    Zhang Q; Chen W; Tan S; Lin T
    Hum Gene Ther; 2017 Jan; 28(1):85-98. PubMed ID: 27762639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human olfactory stem cells: As a promising source of dopaminergic neuron-like cells for treatment of Parkinson's disease.
    Alizadeh R; Kamrava SK; Bagher Z; Farhadi M; Falah M; Moradi F; Boroujeni ME; Soleimani M; Kamyab A; Komeili A
    Neurosci Lett; 2019 Mar; 696():52-59. PubMed ID: 30552942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of functional dopaminergic neurons from human spermatogonial stem cells to rescue parkinsonian phenotypes.
    Yang H; Hao D; Liu C; Huang D; Chen B; Fan H; Liu C; Zhang L; Zhang Q; An J; Zhao J
    Stem Cell Res Ther; 2019 Jun; 10(1):195. PubMed ID: 31248447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulating Wnt signaling to improve cell replacement therapy for Parkinson's disease.
    Parish CL; Thompson LH
    J Mol Cell Biol; 2014 Feb; 6(1):54-63. PubMed ID: 24334258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem cells for cell therapy in Parkinson's disease.
    Lindvall O
    Pharmacol Res; 2003 Apr; 47(4):279-87. PubMed ID: 12644384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem Cell-Based Therapies for Parkinson Disease.
    Liu Z; Cheung HH
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33137927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.